TotalMarketCap

Insmed

INSMNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$22.218 B

$101.74 -3.32%

Close of 8 Oct 2026

As of 8 Oct 2026, Insmed (INSM) has a market capitalization of $22.2B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$606.4M

#1804 by revenue

Earnings

-$1.28B

Loss-making

Shares outstanding

218,381,503

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →
  1. #21Roivant SciencesROIV$25.1B
  2. #22United TherapeuticsUTHR$23.4B
  3. #23InsmedINSM$22.2B
  4. #24ViatrisVTRS$20.1B
  5. #25Ascendis Pharma A/SASND$15.0B

What if Insmed were worth as much as…

Open the what-if tool →

Gold $29.0T

$132,772.24

Per share 1,305× higher

Bitcoin $1.65T

$7,541.98

Per share 74.1× higher

Nvidia $5.72T

$26,206.56

Per share 258× higher

Or at a round number

$50.0B$100.0B$200.0B$500.0B

Where these numbers come from

Share counts and financials for Insmed are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Oct 2026. Read the methodology.